AQNEURSA Granules for oral suspension Ref.[116287] Active ingredients: Levacetylleucine

Source: European Medicines Agency (EU) Revision Year: 2026 Publisher: IntraBio Ireland Ltd, 10 Earlsfort Terrace, Dublin 2, Ireland

Product name and form

Aqneursa 1 g granules for oral suspension in sachet.

Pharmaceutical Form
Granules for oral suspension. White to off-white granules.

Qualitative and quantitative composition

Each sachet contains 1 g levacetylleucine.

Excipients with known effect:

Each sachet contains 642.2 mg isomalt and 0.153 mg propylene glycol.

For the full list of excipients, see section 6.1.

Active Ingredient
Levacetylleucine
Levacetylleucine targets underlying processes of neurological dysfunction. Nonclinical studies demonstrated that levacetylleucine corrects energy metabolism, including improving adenosine triphosphate production.

List of Excipients
Isomalt (E953) Hypromellose Strawberry flavour (contains propylene glycol (E1520))

Pack sizes and marketing

Aqneursa is supplied in single-dose paper-backed aluminium/polyethylene sachets.

Pack sizes:

28 single-dose sachets
multipack containing 112 (4 packs of 28) single-dose sachets

Not all pack sizes may be marketed.

Marketing authorization holder

IntraBio Ireland Ltd, 10 Earlsfort Terrace, Dublin 2, Ireland

Marketing authorization dates and numbers

EU/1/25/1928/001
EU/1/25/1928/002

Drugs

Drug	Countries
AQNEURSA	Austria, Lithuania, United States

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.